Protein Biochemistry, Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
Regeneron Genetic Medicines, Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
J Pharm Biomed Anal. 2023 Nov 30;236:115692. doi: 10.1016/j.jpba.2023.115692. Epub 2023 Sep 2.
The 3' poly(A) tail is an important component of messenger RNA (mRNA). The length of the poly(A) tail has direct impact on the stability and translation efficiency of the mRNA molecule and is therefore considered to be a critical quality attribute (CQA) of mRNA-based therapeutics and vaccines. Various analytical methods have been developed to monitor this CQA. Methods like ion-pair reversed-phase liquid chromatography (IPRP-LC) can be used to quantify the percentage of mRNA with poly(A) tail but fail to provide further information on the actual length of poly(A). High-resolution methods such as liquid chromatography coupled with mass spectrometry (LC-MS) or next generation sequencing (NGS) can separate poly(A) tail length by one nucleotide (n/n + 1 resolution) but are complicated to implement for release testing of manufactured mRNA. In this study, a workflow utilizing capillary gel electrophoresis (CGE) for characterizing the poly(A) tail length of mRNA was developed. The CGE method demonstrated resolution comparable with the LC-MS method. With UV detection and the addition of poly(A) length markers, this method can provide poly(A) tail length information and can also provide quantitation of each poly(A) length, making it a suitable release method to monitor the CQA of poly(A) tail length.
3' 多聚腺苷酸尾巴是信使 RNA(mRNA)的重要组成部分。多聚腺苷酸尾巴的长度直接影响 mRNA 分子的稳定性和翻译效率,因此被认为是基于 mRNA 的治疗药物和疫苗的关键质量属性(CQA)。已经开发了各种分析方法来监测这个 CQA。例如离子对反相液相色谱(IPRP-LC)等方法可用于定量具有多聚腺苷酸尾巴的 mRNA 的百分比,但无法提供有关多聚腺苷酸实际长度的更多信息。高分辨率方法,如液相色谱与质谱联用(LC-MS)或下一代测序(NGS),可以通过一个核苷酸(n/n+1 分辨率)分离多聚腺苷酸尾巴的长度,但对于制造的 mRNA 的放行测试来说实施较为复杂。在这项研究中,开发了一种利用毛细管凝胶电泳(CGE)来表征 mRNA 多聚腺苷酸尾巴长度的工作流程。CGE 方法表现出与 LC-MS 方法相当的分辨率。通过紫外检测和添加多聚腺苷酸长度标记物,该方法可以提供多聚腺苷酸尾巴长度信息,还可以定量每种多聚腺苷酸长度,因此是一种适合监测多聚腺苷酸尾巴长度 CQA 的放行方法。